Jeremy R Chapman1. 1. Department of Renal Medicine, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia. Jeremy_chapman@wsahs.nsw.gov.au
Abstract
PURPOSE OF REVIEW: The research undertaken on 'protocol' renal transplant biopsies has provided a rich, if not the richest, approach to better understanding of the immune and nonimmune impacts upon the transplant. The purpose of this review is to detail how the direct benefit to the patient also lies in these renamed 'surveillance' biopsies. RECENT FINDINGS: Undertaken at fixed time points after transplantation, biopsy provides individual diagnoses with which the clinician can vary immunosuppression both in intensity and in the type of agent used to modify pathological processes early in their course. Initial nonfunction from acute tubular necrosis, subclinical cellular and humoral rejection, calcineurin inhibitor nephrotoxicity, BK virus nephropathy and recurrent glomerulonephritis are all important diagnoses for which early intervention provides better therapeutic outcomes than delaying until they are clinically evident. SUMMARY: This review provides the recent evidence that has convinced many transplant units to embark upon surveillance programmes for their patients in order to individualize their immunosuppression and thus gain better outcomes.
PURPOSE OF REVIEW: The research undertaken on 'protocol' renal transplant biopsies has provided a rich, if not the richest, approach to better understanding of the immune and nonimmune impacts upon the transplant. The purpose of this review is to detail how the direct benefit to the patient also lies in these renamed 'surveillance' biopsies. RECENT FINDINGS: Undertaken at fixed time points after transplantation, biopsy provides individual diagnoses with which the clinician can vary immunosuppression both in intensity and in the type of agent used to modify pathological processes early in their course. Initial nonfunction from acute tubular necrosis, subclinical cellular and humoral rejection, calcineurin inhibitor nephrotoxicity, BK virusnephropathy and recurrent glomerulonephritis are all important diagnoses for which early intervention provides better therapeutic outcomes than delaying until they are clinically evident. SUMMARY: This review provides the recent evidence that has convinced many transplant units to embark upon surveillance programmes for their patients in order to individualize their immunosuppression and thus gain better outcomes.
Authors: Vishal K Varma; Andre Kajdacsy-Balla; Sanjeev K Akkina; Suman Setty; Michael J Walsh Journal: Kidney Int Date: 2016-02-02 Impact factor: 10.612
Authors: Olga Millán; Pablo Ruiz; Lara Orts; Paula Ferré; Gonzalo Crespo; Miguel Santana; Virginia Fortuna; Luís Quintairos; Miguel Navasa; Mercè Brunet Journal: Front Immunol Date: 2019-04-24 Impact factor: 7.561
Authors: Miriam C Banas; Sindy Neumann; Philipp Pagel; Franz Josef Putz; Bernhard K Krämer; Georg A Böhmig; Johannes Eiglsperger; Eric Schiffer; Petra Ruemmele; Bernhard Banas Journal: EBioMedicine Date: 2019-10-21 Impact factor: 8.143
Authors: Miriam C Banas; Georg A Böhmig; Ondrej Viklicky; Lionel P Rostaing; Thomas Jouve; Lluis Guirado; Carme Facundo; Oriol Bestard; Hermann-Josef Gröne; Kazuhiro Kobayashi; Vladimir Hanzal; Franz Josef Putz; Daniel Zecher; Tobias Bergler; Sindy Neumann; Victoria Rothe; Amauri G Schwäble Santamaria; Eric Schiffer; Bernhard Banas Journal: Front Med (Lausanne) Date: 2022-01-07
Authors: Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas Journal: World J Transplant Date: 2016-09-24
Authors: Nele K Kanzelmeyer; Christian Lerch; Thurid Ahlenstiel-Grunow; Jan H Bräsen; Dieter Haffner; Lars Pape Journal: Medicine (Baltimore) Date: 2020-06-05 Impact factor: 1.817